Effect of Enzyme Replacement Therapy on Cardiac Function in Children With Gaucher Disease Type 3
NCT ID: NCT06627543
Last Updated: 2024-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
44 participants
OBSERVATIONAL
2024-04-01
2025-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Sodium-glucose Cotransporter-2 Inhibitors (SGLT-2i) on Proteinuria in Nephrotic Children Older Than 10 Years
NCT06417320
Cardiorespiratory Performance and Pulmonary Microbiome in Patients After Repair of Esophageal Atresia
NCT03767673
Use of a Patient Decision Aid for Gastrologic Endoscopy in a Pediatric Setting
NCT00813033
Effect of Pulsed Magnetic Field Versus Low Level Laser Therapy on Functional Performance in Children With Juvenile Idiopathic Arthritis
NCT06226012
Flourishâ„¢ Pediatric Esophageal Atresia
NCT03615495
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gaucher type patients
echo
echocardiographic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
echo
echocardiographic
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No age limit
* Gaucher disease type 3
* Receiving enzyme replacement therapy
Exclusion Criteria
* Cases of gaucher type 1 and 2
* Other lipid storage disease
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Noha Osman
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Noha Osman
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahmed Mohammed Mohammed
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04-2023-100034
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.